CD117 CAR-T cells (donor-derived)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD117 CAR-T cells (donor-derived), covering 2025-08-27 to 2025-08-27. Get the full timeline:
Most recent: Clinical Trial Update: Donor Derived CD117 CAR-T Cells in the Treatment of R/R Acute Myeloid Leukemia [EARLY_Phase 1]